Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe major depressive disorder (MDD) in adults aged 18 years and older.
Transcranial alternating current stimulation (tACS), a noninvasive technique that uses low-intensity electrical currents to modulate brain activity, is an effective intervention for treating chronic ...
Paul Fitzgerald is a founder of TMS Clinics Australia / Monarch Mental Health Group which provides rTMS therapy through 21 clinics in three states of Australia. He has received grant funding from the ...
Explore therapeutic choices for patients with treatment-resistant depression, including ketamine, psilocybin, and various ...
It's another one of those nights. You lay in bed, frustration rising because no matter what you do, you can’t sleep. Your sound machine is going, your leg is kicked out from under the comforter to ...
A study reveals that the effectiveness of brain stimulation on motor skills is determined by an individual's learning ability rather than age, highlighting the need for a more personalized approach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback